Abstract
Explore the studied 150–300 mg self-trial range for 5-HTP, why to screen serotonergic drugs first, and how SSRIs and MAOIs may raise serotonin-syndrome risk. Independent technical note mirroring the canonical version: https://aimentalhealthadvisor.com/blog/5-htp-150300-mg-screen-serotonergic-drugs-first.php
Keywords
- Treatment of Major Depression
- 5-hydroxytryptophan
- serotonin
- serotonergic drugs
- serotonin syndrome
- selective serotonin reuptake inhibitors
- monoamine oxidase inhibitors
- drug interactions
- Open access
Source
This is a preprint: it has not been peer reviewed yet, and its findings may change.
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.